Gary W. Falk

Gary W. Falk

Auto-generated profile, based on publicly available information

Gary W. Falk

Division of Gastroenterology and Hepatology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

Research Focus & Metrics

Academic Career Length

50Years (1977-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2011 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
CLChris A. Liacouras
Chris A. Liacouras
GFGlenn T. Furuta
Glenn T. Furuta
IHIkuo Hirano
Ikuo Hirano
DADan Atkins
Dan Atkins
SAStephen E. Attwood
Stephen E. Attwood
SASeema S. Aceves
Seema S. Aceves

28 May 2009 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
NSNicholas J. Shaheen
Nicholas J. Shaheen
PSPrateek Sharma
Prateek Sharma
BOBergein F. Overholt
Bergein F. Overholt
HWHerbert C. Wolfsen
Herbert C. Wolfsen
RSRichard E. Sampliner
Richard E. Sampliner
CLCharles J. Lightdale
Charles J. Lightdale
Barrett's esophagus, a condition of intestinal metaplasia of the esophagus, is associated with an increased risk of esophageal adenocarcinoma. We assessed whether endoscopic radiofrequency ablation could eradicate dysplastic Barrett's esophagus and decrease the rate of neoplastic progression. In a multicenter, sham-controlled trial, we randomly assigned 127 patients with dysplastic Barrett's esophagus in a 2:1 ratio to receive either radiofrequency ablation (ablation group) or a sham procedure (control group). Randomization was stratified according to the grade of dysplasia and the length of Barrett's esophagus. Primary outcomes at 12 months included the complete eradication of dysplasia and intestinal metaplasia. In the intention-to-treat analyses, among patients with low-grade dysplasia, complete eradication of dysplasia occurred in 90.5% of those in the ablation group, as compared with 22.7% of those in the control group (P<0.001). Among patients with high-grade dysplasia, complete eradication occurred in 81.0% of those in the ablation group, as compared with 19.0% of those in the control group (P<0.001). Overall, 77.4% of patients in the ablation group had complete eradication of intestinal metaplasia, as compared with 2.3% of those in the control group (P<0.001). Patients in the ablation group had less disease progression (3.6% vs. 16.3%, P=0.03) and fewer cancers (1.2% vs. 9.3%, P=0.045). Patients reported having more chest pain after the ablation procedure than after the sham procedure. In the ablation group, one patient had upper gastrointestinal hemorrhage, and five patients (6.0%) had esophageal stricture. In patients with dysplastic Barrett's esophagus, radiofrequency ablation was associated with a high rate of complete eradication of both dysplasia and intestinal metaplasia and a reduced risk of disease progression. (ClinicalTrials.gov number, NCT00282672.)

1 July 2004 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
PSPrateek Sharma
Prateek Sharma
KMKenneth McQuaid
Kenneth McQuaid
JDJohn Dent
John Dent
MFM.BRian Fennerty
M.BRian Fennerty
RSRichard Sampliner
Richard Sampliner
WWWilfred Weinstein
Wilfred Weinstein

21 July 2013 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MNMario Noti
Mario Noti
ETElia Tait-Woijno
Elia Tait-Woijno
BKBrian S Kim
Brian S Kim
MSMark C Siracusa
Mark C Siracusa
PGPaul Giacomin
Paul Giacomin
DADavid Artis
David Artis

1 August 2011 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
NSNicholas J. Shaheen
Nicholas J. Shaheen
BOBergein F. Overholt
Bergein F. Overholt
RSRichard E. Sampliner
Richard E. Sampliner
HWHerbert C. Wolfsen
Herbert C. Wolfsen
KWKenneth K. Wang
Kenneth K. Wang
CLCharles J. Lightdale
Charles J. Lightdale

1 May 2006 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PSPrateek Sharma
Prateek Sharma
GFGary W. Falk
Gary W. Falk
AWAllan P. Weston
Allan P. Weston
DRDean Reker
Dean Reker
MJMark Johnston
Mark Johnston
RSRichard E. Sampliner
Richard E. Sampliner